These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27462593)

  • 1. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation.
    Oh J; Lee HJ; Lee TS; Kim JH; Koh SB; Choi YS
    Obstet Gynecol Sci; 2016 Jul; 59(4):269-78. PubMed ID: 27462593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH; Yu M; Jeong S; Lee JH
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
    J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
    Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice.
    Shimura K; Mabuchi S; Yokoi T; Sasano T; Sawada K; Hamasaki T; Kimura T
    J Gynecol Oncol; 2013 Oct; 24(4):321-9. PubMed ID: 24167667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
    Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
    Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance.
    Oh J; Bae JY
    Obstet Gynecol Sci; 2018 May; 61(3):337-343. PubMed ID: 29780775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of squamous cell carcinoma antigen in prognostication, monitoring of treatment response, and surveillance of locally advanced cervical carcinoma.
    Tony V; Sathyamurthy A; Ramireddy JK; Iswarya SJ; Gowri SM; Thomas A; Peedicayil A; Ram TS
    J Cancer Res Ther; 2023; 19(5):1236-1240. PubMed ID: 37787289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the relationship between serum squamous cell carcinoma antigen (SCC-Ag) concentration in patients with locally advanced squamous cell carcinoma of the uterine cervix and the risk of relapse.
    Kubik S; Moszynska-Zielinska M; Fijuth J; Tomalczyk A; Jesionek-Kupnicka D; Ura L; Gottwald LM
    Prz Menopauzalny; 2019 Apr; 18(1):23-26. PubMed ID: 31114454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 13. The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.
    Ryu HK; Baek JS; Kang WD; Kim SM
    Obstet Gynecol Sci; 2015 Sep; 58(5):368-76. PubMed ID: 26430661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Combining
    Sookha RR; Zhi W; Shen Y; Lazare C; Wang L; Meng Y; Cao C; Hu J; Wu P
    J Cancer; 2018; 9(17):3101-3108. PubMed ID: 30210633
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
    Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma.
    Wang Y; Cui T; Du L; Xu X; Tian B; Sun T; Han C; Zhao X; Jing J
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27435426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.
    Chang TC; Law KS; Hong JH; Lai CH; Ng KK; Hsueh S; See LC; Chang YC; Tsai CS; Chou HH; Huang KG; Liou JD; Lin CT; Chao A; Chen MY; Wu TI; Ma SY; Yen TC
    Cancer; 2004 Jul; 101(1):164-71. PubMed ID: 15222002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
    Charakorn C; Thadanipon K; Chaijindaratana S; Rattanasiri S; Numthavaj P; Thakkinstian A
    Gynecol Oncol; 2018 Jul; 150(1):190-200. PubMed ID: 29606483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy.
    Wen YF; Cheng TT; Chen XL; Huang WJ; Peng HH; Zhou TC; Lin XD; Zeng LS
    PLoS One; 2018; 13(10):e0204334. PubMed ID: 30303986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.
    Fu J; Wang W; Wang Y; Liu C; Wang P
    Radiat Oncol; 2019 Aug; 14(1):146. PubMed ID: 31416463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.